PPT-SMART Precision Cancer Medicine

Jeremy Warner MD MS Assistant Professor of Medicine and Biomedical Informatics Vanderbilt University June 26 2017 Three questions every cancer patient asks Whos like me How long have I got. From Promise to Practice. PRECISION ONCOLOGY IS THE FUTURE OF CANCER CARE.. Tumor genome data informs cancer treatment and clinical pathways, resulting in better health outcomes.. New cancer therapies target the molecular pathways that lead to tumor genesis and progression.. Apostolia M. Tsimberidou, . MD, PhD. Professor . Investigational Cancer Therapeutics. Incorporation of Levels of Evidence into Variant Reporting/Clinical Practice. Implementation of CAP, AMP, ASCO recommendations. Monday, November 14, 2016. Session Objectives. Understand . Precision Medicine and why a diverse cohort is crucial for success. Describe the nuanced issues in Precision Medicine and genetic research as applied to Native populations. 1. 2015 Precision Medicine Initiative: . Two Components: Cancer & National Cohort. “. An emerging approach for disease prevention and treatment that takes into account people’s individual variations in genes, environment, and lifestyle”. Robert A. Somer, MD. Head, Medical Oncology and Hematology. Director, Office of Clinical Research. MD Anderson Cancer Center- Cooper. What is Cancer?. Official Definition: A malignant proliferation of cells that is a result of a . 12:00- 1:00 pm. Vice . Chancellor for Science Policy and Strategy, UCSF; . Director. , UCSF Precision Medicine; . Vice . Dean for Research, School of . Medicine; . Professor. , Cellular & Molecular . are Failing Most Persons with Cancer by Blocking. Access. . To Precision Diagnostics and Drugs. Workshop: Pharmaceutical Pricing and Marketing: Markets Versus Regulation. ASU University. Tempe, Arizona. 2018 . AACR Annual Meeting. April 15, 2018 . Edward Chu, MD. UPMC Hillman Cancer Center. University of Pittsburgh School of Medicine. Drug . “. A. ”. Time (years) . Percent . One Size Fits All Approach. Introduction. How Has Precision Medicine Changed the Treatment Landscape in Oncology?. Selection of Biomarkers in Drug Development. Methods to Identify Driver Mutations. Which Method Should Be Used?. ValueAwareness,Testing & Educate stakeholders on the value including physicians, pathologists, payers, patient Develop EU and UK-wide guidelines to promote the use of comprehensive testing at various Karen L. Edwards, . PhD. Professor, Dept. of Epidemiology. School of Medicine. University of . California, Irvine. Irvine, CA. Outline. Two National Initiatives . Precision Medicine Initiative . Cancer . Editor, science translational medicine. Science. family of Journals. Kiki . forsythe. , MLS. Senior . publishER. Relations specialist. Science. family of Journals. Defining and Publishing . . Translational Medicine. Biochemistry. qxsang@chem.fsu.edu. Biochemical, Molecular, and Pathological Mechanisms of Cancer, Stroke, Obesity, and Stem Cell Differentiation, and Cancer Biomarker and Drug Discovery for Precision . Owen Tan. 1. , Deborah Schofield. 1. , Rupendra Shrestha. 1. 1. GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie Business School, Macquarie University, Australia.. Presenting at: .